Table 2

Baseline lipoprotein levels

ParameterRosuvastatinAtorvastatinPlacebo
n12210155
HDL-C (mmol/l)1.1 ± 0.21.2 ± 0.21.2 ± 0.2
HDL-P (μmol/l)28 ± 629 ± 631 ± 6
ApoA-I (mg/dl)146 ± 26151 ± 25152 ± 21
LDL-C (mmol/l)4.3 ± 0.64.4 ± 0.64.4 ± 0.7
Non-HDL-C (mmol/l)5.3 ± 0.75.3 ± 0.85.4 ± 0.8
Total cholesterol (mmol/l)6.4 ± 0.76.5 ± 0.86.6 ± 0.8
LDL-P (nmol/l)1,962 ± 3831,869 ± 3672,018 ± 440
ApoB (mg/dl)160 ± 24161 ± 26164 ± 28
VLDL-P (nmol/l)109 ± 35104 ± 37105 ± 34
Triglycerides (mmol/l)2.3 ± 0.82.1 ± 0.72.5 ± 0.9
C-reactive protein (mg/l)2.22.92.6
  • Data are means ± SD or median. HDL-C, HDL cholesterol; HDL-P, HDL particle concentration; LDL-C, LDL cholesterol; LDL-P, LDL particle concentration; non-HDL-C, non-HDL cholesterol; VLDL-P, VLDL particle concentration.